by Team Small News | Sep 22, 2025 | Biocon, Pharma
Biocon, a prominent Indian biopharmaceutical company, has taken a significant step forward by opening its first manufacturing facility in the United States. Located in New Jersey, this facility marks a major milestone for the company as it expands its global presence.... by Team Small News | Sep 21, 2025 | Biocon, Pharma
Biocon, a prominent biopharmaceutical company, has received approval from the Central Drugs Standard Control Organisation (CDSCO) panel to import Aflibercept injection for the treatment of eye disorders. Aflibercept is a recombinant fusion protein that acts as a... by Team Small News | Sep 16, 2025 | Biocon, Pharma
International pharmaceutical companies are increasing their investments in the US to be closer to key markets and mitigate the risks of global trade and supply chain disruptions. Despite pharmaceutical imports being exempt from US tariffs, President Trump’s... by Team Small News | Sep 15, 2025 | Biocon, Pharma
On September 15, 2025, the Biocon Foundation, the corporate social responsibility arm of the Biocon Group, launched the construction of a new Government High School building in Kodamballi, Channapatna Taluk, Karnataka. The school currently serves over 250 children...
by Team Small News | Sep 14, 2025 | Aurobindo Pharma, Biocon, Cipla, Glenmark, Lupin, Mankind, Pharma, Sun Pharma, Torrent Pharma, Zydus
The pharmaceutical industry is complex, with various segments such as innovator products, generics, branded generics, and API. Indian companies are making headway globally, and understanding the industry’s intricacies is crucial for those seeking opportunities.... by Team Small News | Sep 13, 2025 | Biocon, Pharma
On September 12, 2025, Biocon Limited, a global biopharmaceutical company from India, announced the inauguration of its first US manufacturing facility in Cranbury, New Jersey. The facility, acquired from Eywa Pharma Inc. in 2023, has undergone a $30 million...